← Open Payments lookup

JENNIFER FAULKNER-DUPHINEY: Open Payments

NPI 1972284511 · DENVILLE, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,589 in 92 payments from 21 companies in 2025. Trend: 2023 $278 · 2024 $1,032 · 2025 $1,589

Food & beverage: $1,589
CompanyPaymentsAmount
ABBVIE INC.22$317
Novo Nordisk Inc9$249
Axsome Therapeutics, Inc.11$182
PFIZER INC.11$159
Amgen Inc.7$119
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$110
Lilly USA, LLC3$50
Janssen Pharmaceuticals, Inc3$48
Kowa Pharmaceuticals America, Inc.3$48
AstraZeneca Pharmaceuticals LP3$48

Products named: UBRELVY, Wegovy, Auvelity, CAPLYTA, ELIQUIS, OTEZLA, PREVNAR 20, MOUNJARO.

Industry payments across NJ — which companies pay providers there.